$54B AbbVie-Shire deal in jeopardy as Shire stock tumbles By: Philadelphia Business Journal via Business Journals October 15, 2014 at 07:45 AM EDT AbbVie's proposed $54.8 billion acquisition of Shire is in doubt, a result of the federal government’s efforts to curtail “tax inversion deals... Read More >> Related Stocks: AbbVie